Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Index
-
P/E
-
EPS (ttm)
-0.01
Insider Own
88.56%
Shs Outstand
494.49M
Perf Week
4.57%
Market Cap
15.94B
Forward P/E
-
EPS next Y
-
Insider Trans
0.00%
Shs Float
56.59M
Perf Month
34.33%
Enterprise Value
15.94B
PEG
-
EPS next Q
-
Inst Own
0.11%
Perf Quarter
-29.59%
Income
-3.58M
P/S
-
EPS this Y
-
Inst Trans
-7.58%
Perf Half Y
74.84%
Sales
0.00M
P/B
3279.76
EPS next Y
-
ROA
-50.50%
Perf YTD
53.52%
Book/sh
0.01
P/C
3253.54
EPS next 5Y
-
ROE
-54.81%
52W High
83.60 -61.44%
Perf Year
3276.85%
Cash/sh
0.01
P/FCF
-
EPS past 3/5Y
22.39% -33.47%
ROIC
-70.39%
52W Low
0.70 4484.52%
Perf 3Y
4354.98%
Dividend Est.
-
EV/EBITDA
-
Sales past 3/5Y
- -
Gross Margin
-
Volatility
8.03% 13.36%
Perf 5Y
-
Dividend TTM
-
EV/Sales
-
EPS Y/Y TTM
17.24%
Oper. Margin
-
ATR (14)
3.53
Perf 10Y
-
Dividend Ex-Date
-
Quick Ratio
7.39
Sales Y/Y TTM
-
Profit Margin
-
RSI (14)
60.21
Recom
-
Dividend Gr. 3/5Y
- -
Current Ratio
7.39
EPS Q/Q
22.22%
SMA20
19.11%
Beta
2.13
Target Price
-
Payout
-
Debt/Eq
0.11
Sales Q/Q
-
SMA50
19.63%
Rel Volume
0.58
Prev Close
28.82
Employees
10
LT Debt/Eq
0.05
Earnings
-
SMA200
61.98%
Avg Volume
248.96K
Price
32.24
IPO
Jul 16, 2021
Option/Short
Yes / Yes
EPS/Sales Surpr.
- -
Trades
Volume
143,760
Change
11.87%
Feb-19-26 12:28PM
Feb-13-26 10:01AM
Feb-01-26 02:31PM
Jan-27-26 05:30AM
Jan-18-26 12:31PM
08:01AM Loading…
Jan-11-26 08:01AM
Dec-11-25 08:24PM
Nov-24-25 09:05AM
Oct-22-25 05:47PM
Oct-01-25 01:39PM
Sep-04-25 01:01PM
Sep-03-25 03:51AM
Aug-04-25 03:51AM
Jul-31-25 11:31PM
Jul-17-25 03:51PM
02:26PM Loading…
Jul-08-25 02:26PM
Jul-07-25 10:34AM
Jul-01-25 03:51AM
Jun-30-25 04:03PM
Jun-27-25 12:05PM
05:18AM
Jun-20-25 03:06AM
Jun-17-25 12:43PM
12:25PM
Jun-16-25 04:30PM
11:00AM
Apr-30-25 06:01AM
Mar-22-25 11:00AM
Mar-21-25 06:35AM
Mar-17-25 07:28AM
04:02PM Loading…
Jul-23-24 04:02PM
Nov-15-23 04:31PM
Jul-31-23 08:15AM
Apr-03-23 07:25AM
Feb-21-23 06:36AM
Nov-21-22 06:49AM
Nov-15-22 07:55AM
Oct-25-22 06:55AM
Sep-14-22 06:55AM
Sep-12-22 09:15AM
Jun-20-22 05:27AM
May-24-22 05:46AM
May-18-22 08:05AM
06:14AM
May-16-22 08:56AM
Apr-14-22 10:03AM
Apr-07-22 06:09AM
Mar-01-22 08:30AM
Feb-17-22 11:40AM
Feb-16-22 08:42PM
Dec-13-21 08:35AM
Nov-22-21 08:15AM
08:00AM
Nov-02-21 04:00AM
Oct-19-21 11:44AM
Sep-10-21 06:18AM
02:42AM
Sep-02-21 08:00AM
Aug-20-21 08:00AM
Aug-05-21 08:00AM
Jul-20-21 04:05PM
Jul-16-21 11:43AM
Regencell Bioscience Holdings Ltd. is a early-stage bioscience company that focuses on research, development and commercialization of Traditional Chinese Medicine for the treatment of neurocognitive disorders and degeneration, specifically Attention Deficit Hyperactivity Disorder and Autism Spectrum Disorder. The company was founded by Yat-Gai Au on October 30, 2014 and is headquartered in Hong Kong.